Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Flynn James E Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 SC 13G/A Flynn James E reports a 0% stake in Terns Pharmaceuticals, Inc.
10/04/2023 SC 13G/A Flynn James E reports a 0% stake in Evolus, Inc.
08/14/2023 SC 13G/A Flynn James E reports a 7.4% stake in Singular Genomics Systems, Inc.
08/01/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2023 4 Flynn James E (10% Owner) has filed a Form 4 on Nuvalent, Inc.
Txns: Granted 15,000 options to buy @ $44.68, valued at $670.2k
06/12/2023 4 Flynn James E (10% Owner) has filed a Form 4 on CareMax, Inc.
Txns: Granted 33,750 options to buy @ $0
06/09/2023 SC 13G/A Flynn James E reports a 4.9% stake in GeneDX Holdings Corp.
05/26/2023 SC 13G Flynn James E reports a 5.9% stake in Cabaletta Bio, Inc.
05/23/2023 SC 13D/A Flynn James E reports a 4.9% stake in CalciMedica, Inc.
05/18/2023 SC 13G Flynn James E reports a 5.5% stake in Amedisys, Inc.
05/11/2023 4 Flynn James E (10% Owner) has filed a Form 4 on Larimar Therapeutics, Inc.
Txns: Granted 8,300 options to buy @ $5.09, valued at $42.2k
05/10/2023 SC 13G/A Flynn James E reports a 0% stake in Rain Oncology Inc.
05/03/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
04/06/2023 SC 13G Flynn James E reports a 5.5% stake in Owens & Minor, Inc.
03/28/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/27/2023 SC 13D/A Flynn James E reports a 24.5% stake in CalciMedica, Inc.
03/22/2023 SC 13G Flynn James E reports a 6.1% stake in Deciphera Pharmaceuticals, Inc.
02/13/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Flynn James E reports a 39.2% stake in Nuvalent, Inc.
02/10/2023 SC 13G/A Flynn James E reports a 5.7% stake in AdaptHealth Corp.
02/10/2023 SC 13G/A Flynn James E reports a 9.1% stake in Singular Genomics Systems, Inc.
02/10/2023 SC 13G/A Flynn James E reports a 1.8% stake in Peak Bio, Inc.
02/10/2023 SC 13G/A Flynn James E reports a 0% stake in Turmeric Acquisition Corp.
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Flynn James E reports a 2.5% stake in Orchard Therapeutics plc
02/10/2023 SC 13G/A Flynn James E reports a 0% stake in Organogenesis Holdings Inc.
02/10/2023 SC 13G/A Flynn James E reports a 3.6% stake in Kura Oncology, Inc.
02/10/2023 SC 13G/A Flynn James E reports a 0% stake in Inozyme Pharma, Inc.
02/10/2023 SC 13G/A Flynn James E reports a 6.2% stake in Edgewise Therapeutics, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy